Načítá se...
Secukinumab: A New Treatment Option for Psoriatic Arthritis
INTRODUCTION: Psoriatic arthritis (PsA) is an immune-mediated chronic inflammatory arthropathy associated with impaired physical function and reduced quality of life. Biologic therapies that target tumor necrosis factor (anti-TNF) have significantly improved clinical outcomes. Partial, non- and tran...
Uloženo v:
| Vydáno v: | Rheumatol Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4999581/ https://ncbi.nlm.nih.gov/pubmed/27747518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-016-0031-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|